STK11 and squamous cell carcinoma: Importantly, a proportion of STK11 deficient human LUAD express squamous cell carcinoma signatures (SCC) and these p63+ lesions express higher levels of the antioxidant transcription factor NRF2 and lower levels of ROS-induced DNA oxidative damage compared with their TTF1+ counterparts46.